Protocols for cytogenetic studies of human embryonic stem cells

被引:57
|
作者
Meisner, Lorraine Faxon [1 ]
Johnson, Julie A.
机构
[1] Univ Wisconsin, Dept Populat Hlth Sci, Madison, WI 53719 USA
关键词
chromosomes; cytogenetics; karyotype; FISH; in-situ hybridization; G-banding; embryonic stem cells; hESC; trisomy; quality assurance;
D O I
10.1016/j.ymeth.2008.03.005
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
All cultured cells develop chromosome changes over time, including cultures of human embryonic stem cells (hESC), but only those cells with adaptive chromosomes changes survive. The most frequent chromosome changes in hESC cultures are trisomy 12 and trisomy 17. Cells with these trisomies are indistinguishable from normal cells by appearance and also demonstrate typical markers of pluripotency, making them difficult to identify without cytogenetic analysis. Early detection of these cells is essential since cells with trisomy 12 and 17 can replace the normal cell population in 5-10 passages. Cytogenetic analysis using G-banding is considered to be the gold standard for detecting chromosome abnormalities and, when used in combination with interphase FISH, provides a sensitive method for early detection of cytogenetic aberrations, such as full and partial trisomies of chromosomes 12 and 17. The following discussion describes the cytogenetic methods used in our laboratory to study cultured hESCs, along with recommendations for integrating these methods into a plan for routine cell line quality control. (c) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:133 / 141
页数:9
相关论文
共 50 条
  • [41] Proteomics of human embryonic stem cells
    Hughes, Chris S.
    Nuhn, Amelia A.
    Postovit, Lynne M.
    Lajoie, Gilles A.
    PROTEOMICS, 2011, 11 (04) : 675 - 690
  • [42] Culture of human embryonic stem cells
    Gerald Schatten
    Joseph Smith
    Christopher Navara
    Jong-Hyuk Park
    Roger Pedersen
    Nature Methods, 2005, 2 : 455 - 463
  • [43] Proteomics and human embryonic stem cells
    Van Hoof, Dennis
    Heck, Albert J. R.
    Krijgsveld, Jeroen
    Mummery, Christine L.
    STEM CELL RESEARCH, 2008, 1 (03) : 169 - 182
  • [44] Customized human embryonic stem cells
    Daley, GQ
    NATURE BIOTECHNOLOGY, 2005, 23 (07) : 826 - 828
  • [45] Glycomics of human embryonic stem cells and human induced pluripotent stem cells
    Furukawa, Jun-ichi
    Okada, Kazue
    Shinohara, Yasuro
    GLYCOCONJUGATE JOURNAL, 2017, 34 (06) : 807 - 815
  • [46] Glycomics of human embryonic stem cells and human induced pluripotent stem cells
    Jun-ichi Furukawa
    Kazue Okada
    Yasuro Shinohara
    Glycoconjugate Journal, 2016, 33 : 707 - 715
  • [47] Glycomics of human embryonic stem cells and human induced pluripotent stem cells
    Jun-ichi Furukawa
    Kazue Okada
    Yasuro Shinohara
    Glycoconjugate Journal, 2017, 34 : 807 - 815
  • [48] Glycomics of human embryonic stem cells and human induced pluripotent stem cells
    Furukawa, Jun-ichi
    Okada, Kazue
    Shinohara, Yasuro
    GLYCOCONJUGATE JOURNAL, 2016, 33 (05) : 707 - 715
  • [49] Statins inhibit the growth of variant human embryonic stem cells and cancer cells in vitro but not normal human embryonic stem cells
    Gauthaman, K.
    Manasi, N.
    Bongso, A.
    BRITISH JOURNAL OF PHARMACOLOGY, 2009, 157 (06) : 962 - 973
  • [50] Optimization of protocols for generation of insulin-producing cells from human embryonic stem cells using small molecules
    He, Jingjing
    Li, Jin
    Sun, Yi
    Lu, Guangxiu
    Lin, Ge
    MATERIALS EXPRESS, 2021, 11 (06) : 863 - 872